BioStock: CE marking for Chordate Medical’s new control unit

Chordate Medical has for some time been developing the next generation of the control unit used in the company’s treatment for chronic rhinitis (nasal congestion). The new version of the control unit is both more efficient and more cost-effective than the previous version, and it has now received an approval from Intertek, which means that the product meets the requirements for CE marking.

Read the full article at biostock.se:
 
https://www.biostock.se/en/ce-marking-for-chordate-medicals-new-control-unit/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se